Country: Malta
Language: English
Source: Medicines Authority
URSODEOXYCHOLIC ACID
Dr. Falk Pharma GmbH Leinenweberstr 579108 Freiburg, Germany
A05AA02
URSODEOXYCHOLIC ACID 250 mg
HARD CAPSULE
URSODEOXYCHOLIC ACID 250 mg
POM
BILE AND LIVER THERAPY
Withdrawn
2005-07-19
PIL02600201 VERSION 3 1 PACKAGE LEAFLET: INFORMATION FOR THE USER URSOFALK 250 MG CAPSULES Ursodeoxycholic acid READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. − Keep this leaflet. You may need to read it again. − If you have any further questions, ask your doctor or pharmacist. − This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. − If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. IN THIS LEAFLET: 1. WHAT URSOFALK 250 MG CAPSULES ARE AND WHAT THEY ARE USED FOR 2. BEFORE YOU TAKE URSOFALK 250 MG CAPSULES 3. HOW TO TAKE URSOFALK 250 MG CAPSULES 4. POSSIBLE SIDE EFFECTS 5. HOW TO STORE URSOFALK 250 MG CAPSULES 6. FURTHER INFORMATION 1. WHAT URSOFALK 250 MG CAPSULES ARE AND WHAT THEY ARE USED FOR Ursodeoxycholic acid, the active substance in Ursofalk 250 mg capsules, is a naturally- occurring bile acid with small amounts found in human bile. URSOFALK 250 MG CAPSULES ARE USED: - to dissolve cholesterol gallstones. These stones must be radiolucent (not visible on a plain X-ray) and no larger than 15 mm in diameter. The gall bladder must still be working despite the gallstone(s). - to treat inflammation of the stomach lining caused by the reflux of bile acids (bile reflux gastritis) - for the symptomatic treatment of primary biliary cirrhosis (PBC which is a disease of the bile ducts up to cirrhosis of the liver), in patients without decompensated liver cirrhosis (diffuse chronic disease of the liver, at a stage Read the complete document
Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT URSOFALK 250 MG CAPSULES Ursodeoxycholic acid 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 hard capsule of Ursofalk 250 mg capsules contains 250 mg ursodeoxycholic acid as the active substance. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Hard capsules Appearance: white, opaque hard gelatin capsules, capsule size 0, which contain a white compressed powder or granulate. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the dissolution of cholesterol gallstones in the gall bladder. The gallstones must not show as shadows on X-ray images and should not exceed 15 mm in diameter. Gall bladder function must not be significantly impaired, despite the gallstones. For the treatment of bile reflux gastritis. For the symptomatic treatment of primary biliary cirrhosis (PBC), in patients without decompensated hepatic cirrhosis. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION There are no age restrictions on the use of Ursofalk 250 mg capsules. For patients weighing less than 47 kg or patients who are unable to swallow Ursofalk 250 mg capsules, Ursofalk 250 mg/5 ml suspension is available. The following daily dose is recommended for the various indications: For dissolution of cholesterol gallstones Approx. 10 mg of ursodeoxycholic acid per kg of body weight, equivalent to: up to 60 kg 2 hard capsules 61 – 80 kg 3 hard capsules 81 – 100 kg 4 hard capsules over 100 kg 5 hard capsules Page 2 of 8 The hard capsules should be swallowed whole with some liquid in the evening at bedtime. The capsules Read the complete document